Loading...
  • prevalence
  • The objective of this research was to construct and compare a 2013 New Zealand population derived from Statistics New Zealand's Integrated Data Infrastructure (IDI) with the 2013 census population and a 2013 Health Service Utilisation population, and to ascertain the differences in cardiovascular disease prevalence. (apo.org.au)
  • Prevalence of small vessel and large vessel disease in diabetic patients from 14 centres: the World Health Organisation multinational study of vascular disease in diabetics. (springer.com)
  • high risk
  • SCORE risk charts for high risk countries (incl. (blogspot.com)
  • Populations that are at high risk for cardiovascular disease with established OSA and no prior history of PAP treatment will be the central focus of this initiative. (nih.gov)
  • Specific goals are to establish feasibility of long-term PAP treatment in high-risk individuals, to evaluate the potential for such treatment to produce changes in cardiovascular disease risk profiles, and to identify feasibility of study design strategies for future event-driven Phase III clinical trials. (nih.gov)
  • differences
  • Rodent CVD models are increasingly used for understanding individual differences in susceptibility to environmental stressors such as air pollution. (epa.gov)
  • Baseline differences in pathology of the heart, lung and kidney, antioxidants and gene expression, along with levels of systemic inflammation and coagulation markers were analyzed to understand distinct disease-related phenotypes. (epa.gov)
  • Ethnic differences in SCORE cardiovascular risk in Oslo, Norway. (fhi.no)
  • outcome
  • Substantial heterogeneity in predictor and outcome definitions was observed between models, and important clinical and methodological information were often missing. (bmj.com)
  • Clinical prediction models estimate the risk of existing disease or future outcome for an individual, which is conditional on the values of multiple predictors such as age, sex, and biomarkers. (bmj.com)
  • diagnostic
  • In the diagnostic setting, the probability that a particular disease is present can be used, for example, to inform the referral of patients for further testing, initiate treatment directly, or reassure patients that a serious cause for their symptoms is unlikely. (biomedcentral.com)
  • Nevertheless, in diagnostic modeling studies, for logistical reasons, a time window between predictor (index test) measurement and the reference standard is often necessary. (biomedcentral.com)
  • QRISK
  • The latest model, QRISK, was developed using a primary care database and our work has reinforced the current debate over analysis methodology in such studies. (uea.ac.uk)
  • vessel disease
  • It is unclear what is driving this association but risk may be conveyed via an increase in neurodegeneration (e.g. amyloid deposition), vascular changes (e.g. small vessel disease) and mechanistically due to increased levels of oxidative stress and inflammation as well as changes in NO bioavailability. (springer.com)
  • In addition to neurovascular (e.g. small vessel disease) and neuropathological (e.g. amyloid disposition) processes, other biological pathways are thought to be involved, such as the nitric oxide (NO), inflammatory (e.g. interleukin-6) and oxidative stress pathways. (springer.com)
  • people
  • People with high triglyceride levels have a greater risk of developing cardiovascular disease than people with lower levels. (blogspot.com)
  • The people with the highest consumption of junk food had a 37% increased risk of being diagnosed with depression compared with the lowest consumption group. (brainblogger.com)
  • patients
  • We also discuss CVD risk scores for diabetic patients that have been developed in different countries. (springer.com)
  • Numerous CVD risk scores for diabetic patients have been created in various settings. (springer.com)
  • First, the studies should be designed to provide information regarding feasibility of long-term (12 to 18 months) PAP treatment of OSA in patients at risk of CVD. (nih.gov)
  • venous
  • and (e) the demonstration that aspirin is effective and cost-saving in preventing recurrent venous thrombo-embolic disease. (edu.au)
  • Medicine
  • Today, Post Rock Family Medicine has been selected by the Centers for Medicare & Medicaid Services (CMS) as one of 516 awardees in 47 states, Puerto Rico, and the District of Columbia to help reduce the risk of heart attacks and strokes among millions of Medicare fee-for-service beneficiaries. (postrock.us)
  • excess
  • Conclusions There is an excess of models predicting incident CVD in the general population. (bmj.com)
  • validation
  • The usefulness of most of the models remains unclear owing to methodological shortcomings, incomplete presentation, and lack of external validation and model impact studies. (bmj.com)
  • future
  • The NO pathway may be a promising biological candidate for future studies focused on reducing not only CVD but also risk of cognitive decline and dementia. (springer.com)